Hi,
moomoo ID:NaN
Log Out
English
Back
Log in to access Online Inquiry
Multi-dimentional Analyses
Company Valuation Capital Tracking Short Selling Data
CBPO CHINA BIOLOGIC PRODUCTS HLDGS INC
0.0000.0000.00%
YOY
Do not show
Hide blank lines
(FY)2020/12/31(Q4)2020/12/31(Q3)2020/09/30(Q2)2020/06/30
Total revenue
4.09% 524.37M 9.76% 112.13M 1.78% 138.54M -18.12% 111.11M
Operating revenue
4.09% 524.37M 11.09% 157.11M 0.29% 122.7M -17.94% 97.82M
Cost of revenue
3.02% 179.94M -1.67% 37.53M -2.94% 46.07M -22.45% 34.74M
Gross profit
4.66% 344.43M 16.57% 74.6M 4.31% 92.47M -15.98% 76.37M
Operating expense
-9.90% 149.05M -7.58% 41.96M 13.47% 40.45M -21.18% 33.68M
Selling and administrative expenses
-8.61% 140.47M -4.85% 39.12M 19.17% 39.28M -23.44% 30.85M
-Selling and marketing expense
-28.90% 57.1M -23.62% 13.91M -19.27% 14.32M -43.79% 14.41M
-General and administrative expense
13.61% 83.37M 10.08% 25.21M 63.96% 24.96M 12.16% 16.44M
Research and development costs
-26.85% 8.58M -33.73% 2.84M -56.36% 1.17M 16.34% 2.83M
Operating profit
19.39% 195.37M 75.52% 32.64M -1.85% 52.02M -11.37% 42.69M
Net non-operating interest income expense
-45.36% 11.35M 120.67% 3.9M -93.87% 413.62K -54.90% 2.61M
Non-operating interest income
-45.27% 11.67M 97.43% 3.96M -92.83% 492.63K -54.61% 2.69M
Non-operating interest expense
-41.88% 324.06K -72.54% 66.28K -37.99% 79.01K -40.92% 73.87K
Other net income (expense)
3.62% 7.34M -39.26% 379.02K 158.55% 3.7M -34.65% 1.85M
Earnings from equity interest
-741.57% -10.18M -13,847.98% -8.38M -325.96% -456.81K -165.20% -555.5K
Other non- operating income (expenses)
218.88% 17.52M 1,180.93% 8.76M 238.28% 4.16M 21.49% 2.41M
Income before tax
11.78% 214.06M 75.91% 36.92M -8.24% 56.13M -16.98% 47.16M
Income tax
27.18% 35.74M 78.00% 7.81M 27.20% 9.71M -19.18% 6.6M
Net income
9.14% 178.32M 75.36% 29.11M -13.29% 46.42M -16.61% 40.56M
Net income continuous Operations
9.14% 178.32M 75.36% 29.11M -13.29% 46.42M -16.61% 40.56M
Minority interest income
5.89% 26.04M 30.98% 5.43M 5.49% 6.88M -30.22% 4.88M
Net income attributable to the parent company
9.71% 152.29M 90.13% 23.67M -15.89% 39.54M -14.32% 35.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
11.06% 152.29M 120.00% 23.67M -15.89% 39.54M -14.32% 35.68M
Basic earnings per share
10.42% 3.92 84.85% 0.61 -15.70% 1.02 -14.02% 0.92
Diluted earnings per share
8.22% 3.82 81.25% 0.58 -18.18% 0.99 -14.15% 0.91
Dividend per share
Currency Unit
USDUSDUSDUSD
Accounting Standards
US-GAAPUS-GAAPUS-GAAPUS-GAAP

FY: Financial Year Annual Report, which is equivalent to the 10-K file disclosed by the listed company to the SEC.

Q: Quarterly report, which is equivalent to the 10-Q file disclosed by the listed company to the SEC, where Q1, Q2, Q3, and Q4 are single quarterly reports with a span of 3 months; Q6 and Q9 are cumulative quarterly reports, and Q6 is 6 months , Q9 is 9 months.

The MOM data from the Quarterly report,MOM=(current period - last period)/last period *100%

Company Overview More
CEO: --
Market: --
Hot List
TradeSearchNews
SymbolLatest price%Chg

Loading...

Watchlist